Skip to main content

Sphera Funds Management Ltd.

SEC CIK
0001496201
Latest filing
Aug 14, 2026

SYRE holding history

Spyre Therapeutics, Inc. in every 13F filed by Sphera Funds Management Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SYRE overviewAll 13F holders of SYREFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2022
Holdings of SYRE by Sphera Funds Management Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−646,478−100.0%Sold outHolders
Q1 2023646,478$187.5K<0.1%+205,641+46.6%AddedHolders
Q4 2022440,837$198.3K0.1%+440,837NewHolders